The "Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the risk factors, comorbidities, ...
Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...
Results provide clinical demonstration of best-in-class immunogenicity achieved with an RNA-based platform and good tolerability RBI-4000's ...
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
3d
News Medical on MSNNatural immunity to SARS-CoV-2 weakened significantly after Omicron’s emergenceFindings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...
The company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.
4d
The Montgomery Advertiser on MSNNew, possibly deadly virus found in Alabama animals. Here's what we know so farResearchers found first strain of henipavirus in North America. What you need to know about new virus in wild animals that ...
Researchers found first henipavirus strain in North America. What you need to know about new virus in wild animals living in ...
Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...
11h
The Healthy on MSNTaking an Antibiotic? Here Are the Questions to Ask Your Doctor FirstMake your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or pharmacy.
While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results